URO17 for detecting bladder cancer

Equality considerations

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others.

Bladder cancer is more common in men than women; 72% of cases in the UK are in men, and 28% are in women. Despite a lower incidence of bladder cancer in women, rates of survival are considerably lower for women than for men. It mainly affects older people with the highest incidence rates in people aged 90 and over (Cancer Research UK, 2015). People of European family origin have a much higher risk of developing bladder cancer than those of African American, Hispanic or Asian family origin. People with cancer are protected under the Equality Act 2010 from the point of diagnosis.